Early Detection Research Network

Overa

Aliases:
This biomarker is also known as:
  • Overa,

Description…

From Vermillion website: Overa, a second-generation Multivariate Index Assay (MIA2G) is an FDA-cleared blood test for women with a pelvic mass who are planned for surgery. Overa (MIA2G) maintains the high level of ovarian cancer detection, across rare subtypes and including early stage cancers, afforded by OVA1 (MIA). However, Overa (MIA2G) incorporates different markers and a refined algorithm in order to improve the balance between ovarian cancer detection and healthcare efficiency. Overa (MIA2G) represents a significant improvement in positive predictive value, overall accuracy and a reduction in false positives and unnecessary referrals. https://vermillion.com/our-products/ova1-ova1plus/

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Protein
HGNC Name:

The following organs have data associated with this biomarker…

Attributes

Phase: Five
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

No associated publications found.

No other associated resources found.

Version 5.0.2